From: Maternal and fetal outcomes of patients with liver cirrhosis: a case-control study
Group A (n = 97) | Group C (n = 194) | t/χ2/Z, P | |
---|---|---|---|
Age (mean ± SD, years) | 30.79 ± 5.01 | 31.38 ± 4.13 | t = 0.993, p = 0.322 |
Gravidity, n (%) | |||
1 | 35 (36.1) | 78 (40.2) | Z = 0.555, p = 0.579 |
2 | 30 (30.9) | 55 (28.4) | |
> 2 | 32 (33) | 61 (31.4) | |
Multipara, n (%) | 32 (33) | 83 (42.8) | χ2 = 2.595, P = 0.107 |
Lab on first visit (mean ± SD) | |||
Platelet (*109/L) | 123.51 ± 66.66 | 239.60 ± 54.70 | t = 15.638, p = 4.34*10− 40 |
Hemoglobin(g/L) | 117.37 ± 14.91 | 124.97 ± 14.13 | t = 4.191, p = 3.7*10−7 |
ALT (IU/L) | 43.38 ± 60.49 | 20.74 ± 21.42 | t = 3.539, p = 5.98*10− 4 |
Albumin(g/L) | 39.49 ± 5.22 | 43.85 ± 27.17 | t = 1.549, p = 0.123 |
Total Bilirubin (umol/L) | 20.35 ± 39.31 | 11.00 ± 6.78 | t = 2.302, p = 0.023 |
Prothrombin activity (%) | 96.79 ± 17.27 | 105.87 ± 11.14 | t = 4.579, p = 1.0*10−5 |
Creatinine (umol/L) | 45.72 ± 7.49 | 43.00 ± 6.65 | t = 3.084, p = 2.25*10−3 |